The Calcium Rationale in Aging and Alzheimer's Disease

Calcium is required for the function of all cells in the body, including neurons. Considerable research has described the function of calcium in the regulation of numerous processes including neurotransmitter release, cytoarchitecture and growth, and activation of enzyme systems including kinases and phosphatases. Calcium is intimately involved in a variety of “plastic” changes in the brain. For example, during adaptive processes such as learning and development, changes in transmembrane calcium fluxes correlate with changes in neuronal excitability and structural connectivity. Calcium thus is likely to have key roles in the cellular processes underlying aging-related changes in the brain, including normal age-associated memory impairments as well as more severe dementias, including Alzheimer’s disease. The pivotal role of calcium in so many neuronal processes dictates the need for precise regulation of its intracellular levels. Any dysregulation, however subtle, could lead to dramatic changes in normal neuronal function. Recent studies from our laboratory and those of others have implicated altered calcium influx with agingrelated changes at both the behavioral and the neurophysiological levels. These findings led to and continue to support the calcium hypothesis’s* which posits that in the aging brain, transient or sustained increases in the average concentration of intracellular free calcium contribute to impaired function, eventually leading to cell death. The hypothesis suggests that the final common pathway that may contribute to cognitive deterioration of aging vertebrates, including persons with Alzheimer’s disease or other aging-related dementias, is increased free calcium within neurons. The functional impairment that characterizes a patient at a particular time in the aging-related disease process may be relieved by reducing excessive calcium influx. Additionally, because calcium dysregulation terminating in cell death is likely to be

[1]  Lucien T. Thompson,et al.  Trace eyeblink conditioning in rabbits demonstrates heterogeneity of learning ability both between and within age groups , 1996, Neurobiology of Aging.

[2]  J. Disterhoft,et al.  Dihydropyridine-sensitive calcium channels in acutely-dissociated hippocampal CA1 neurons , 1994 .

[3]  J. Disterhoft,et al.  Relation of Nimodipine Dose and Serum Concentration to Learning Enhancement in Aging Rabbits , 1994, Experimental Neurology.

[4]  J. Disterhoft,et al.  Nimodipine decreases calcium action potentials in rabbit hippocampal CA1 neurons in an age‐dependent and concentration‐dependent manner , 1994, Hippocampus.

[5]  N. Porter,et al.  Low Ba2+ and Ca2+ induce a sustained high probability of repolarization openings of L-type Ca2+ channels in hippocampal neurons: physiological implications. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[7]  Mark P. Mattson,et al.  Calcium as sculptor and destroyer of neural circuitry , 1992, Experimental Gerontology.

[8]  J F Disterhoft,et al.  Nimodipine increases excitability of rabbit CA1 pyramidal neurons in an age- and concentration-dependent manner. , 1992, Journal of neurophysiology.

[9]  D. Commenges,et al.  Occupation during life and memory performance in nondemented French elderly community residents , 1992, Neurology.

[10]  D. Selkoe,et al.  Aging brain, aging mind. , 1992, Scientific American.

[11]  A. Walker,et al.  Old age and cognition: Enhancement of recent memory in aged rats by the calcium channel blocker nimodipine , 1992, Neurobiology of Aging.

[12]  L. Jarvik Calcium channel blocker nimodipine for primary degenerative dementia , 1991, Biological Psychiatry.

[13]  P. Dutar,et al.  Loss of Calbindin‐28K Immunoreactivity in Hippocampal Slices from Aged Rats: a Role for Calcium? , 1991, The European journal of neuroscience.

[14]  P. Solomon,et al.  Disruption of classical conditioning in patients with Alzheimer's disease , 1991, Neurobiology of Aging.

[15]  M. Fahim,et al.  Aging increases calcium influx at motor nerve terminal , 1990, International Journal of Developmental Neuroscience.

[16]  L. Morey,et al.  Nimodipine in the treatment of old age dementias , 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[17]  Lucien T. Thompson,et al.  Nimodipine enhances spontaneous activity of hippocampal pyramidal neurons in aging rabbits at a dose that facilitates associative learning , 1990, Brain Research.

[18]  J. Disterhoft,et al.  Dietary nimodipine improves associative learning in aging rabbits , 1990, Neurobiology of Aging.

[19]  William A. Catterall,et al.  Clustering of L-type Ca2+ channels at the base of major dendrites in hippocampal pyramidal neurons , 1990, Nature.

[20]  D. Woodruff-Pak,et al.  Eyeblink conditioning discriminates Alzheimer's patients from non-demented aged. , 1990, Neuroreport.

[21]  T. E. Levere,et al.  Aging and cognition: Facilitation of recent memory in aged nonhuman primates by nimodipine , 1990, Neurobiology of Aging.

[22]  J. Garthwaite,et al.  Excitatory amino acid neurotoxicity and neurodegenerative disease. , 1990, Trends in pharmacological sciences.

[23]  G. Tollefson Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia , 1990, Biological Psychiatry.

[24]  M. Albert,et al.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.

[25]  Z. Khachaturian The role of calcium regulation in brain aging: reexamination of a hypothesis , 1989, Aging.

[26]  D. Alkon,et al.  Classical conditioning reduces amplitude and duration of calcium-dependent afterhyperpolarization in rabbit hippocampal pyramidal cells. , 1989, Journal of neurophysiology.

[27]  J. Traber,et al.  Pharmacological basis for the use of nimodipine in central nervous system disorders , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  J. Disterhoft,et al.  Nimodipine facilitates associative learning in aging rabbits. , 1989, Science.

[29]  S. B. Kater,et al.  Calcium regulation of the neuronal growth cone , 1988, Trends in Neurosciences.

[30]  R. Tsien,et al.  Multiple types of neuronal calcium channels and their selective modulation , 1988, Trends in Neurosciences.

[31]  D. Alkon,et al.  AHP reductions in rabbit hippocampal neurons during conditioning correlate with acquisition of the learned response , 1988, Brain Research.

[32]  D. Choi,et al.  Glutamate neurotoxicity and diseases of the nervous system , 1988, Neuron.

[33]  Robert Siman,et al.  Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo , 1988, Neuron.

[34]  D. Alkon,et al.  Classical conditioning induces long-term translocation of protein kinase C in rabbit hippocampal CA1 cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[35]  P. Landfield ‘Increased calcium-current’ hypothesis of brain aging , 1987, Neurobiology of Aging.

[36]  P. Landfield,et al.  Probable Ca2+-mediated inactivation of Ca2+ currents in mammalian brain neurons , 1987, Brain Research.

[37]  Richard F. Thompson,et al.  Hippocampus and trace conditioning of the rabbit's classically conditioned nictitating membrane response. , 1986, Behavioral neuroscience.

[38]  T. A. Pitler,et al.  The effects of high Mg2+-to-Ca2+ ratios on frequency potentiation in hippocampal slices of young and aged rats. , 1986, Journal of neurophysiology.

[39]  P. Adams,et al.  Calcium-dependent current generating the afterhyperpolarization of hippocampal neurons. , 1986, Journal of neurophysiology.

[40]  F. Morrell,et al.  Loss of perforated synapses in the dentate gyrus: morphological substrate of memory deficit in aged rats. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Alkon,et al.  Conditioning-specific membrane changes of rabbit hippocampal neurons measured in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Nicoll,et al.  Phorbol esters mimic some cholinergic actions in hippocampal pyramidal neurons , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  D. Nicholls,et al.  Subsynaptosomal distribution of calcium during aging and 3,4-diaminopyridine treatment , 1985, Neurobiology of Aging.

[44]  T. A. Pitler,et al.  Prolonged Ca2+-dependent afterhyperpolarizations in hippocampal neurons of aged rats. , 1984, Science.

[45]  P. Landfield,et al.  Chronically elevating plasma Mg2+ improves hippocampal frequency potentiation and reversal learning in aged and young rats , 1984, Brain Research.

[46]  G. Gibson,et al.  Aging and 3,4-diaminopyridine alter synaptosomal calcium uptake. , 1983, The Journal of biological chemistry.

[47]  D. Prince,et al.  A calcium-activated hyperpolarization follows repetitive firing in hippocampal neurons. , 1980, Journal of neurophysiology.

[48]  C. Barnes Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. , 1979, Journal of comparative and physiological psychology.

[49]  Richard F. Thompson,et al.  Neuronal plasticity in the limbic system during classical conditioning of the rabbit nictitating membrane response. I. The hippocampus , 1978, Brain Research.

[50]  S. B. Kater,et al.  Role of intracellular calcium in NI-35-evoked collapse of neuronal growth cones. , 1993, Science.

[51]  Joel L. Davis,et al.  Long-term potentiation : a debate of current issues , 1991 .

[52]  G. Basile,et al.  EFFECT OF NIMODIPINE ON CHRONIC ORGANIC BRAIN SYNDROME : ANALYSIS OF PERFORMANCE TESTS DURING MEDIUM-TERM TREATMENT WITH THE CALCIUM ANTAGONIST , 1990 .

[53]  J. Disterhoft,et al.  Nimodipine ameliorates aging-related changes in open-field behaviors of the rabbit. , 1989, Experimental aging research.

[54]  E. Rüther,et al.  Therapeutic Results with Nimodipine in Primary Degenerative Dementia and Multi-Infarct Dementia , 1989 .

[55]  J. Bigorra,et al.  Nimodipine Treatment Improves Cognitive Functions in Vascular Dementia , 1989 .

[56]  J. Dýcka,et al.  Nimodipine for Psychogeriatric Use: Methods, Strategies, and Considerations Based on Experience with Clinical Trials , 1989 .

[57]  L. Drewes,et al.  Transfer of Nimodipine and Another Calcium Antagonist Across the Blood-Brain Barrier and Their Regional Distribution In Vivo , 1989 .

[58]  C. Bergeron,et al.  CALMODULIN AND CALBINDIN D28K IN ALZHEIMER DISEASE , 1987, Alzheimer disease and associated disorders.

[59]  D. Woodruff-Pak,et al.  Classical conditioning of the eyelid response in rabbits as a model system for the study of brain mechanisms of learning and memory in aging. , 1985, Experimental aging research.

[60]  C. W. Greene THE AMERICAN PHYSIOLOGICAL SOCIETY. , 1924, Science.

[61]  A. Nappi,et al.  Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .